Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

Image Modified







Project Scope

Development of R-shiny application(s) an open-source tool and package to enable the generation of identified of identified interactive plots for clinical review and direct inclusion in submission packages for submissions to regulatory agencies. Initial The initial scope is to develop tools a package to generate interactive forest and volcano plots for adverse events and FDA Medical Queries (FMQs) analysis outputs for inclusion in submission submissions to the FDA. This work is in conjunction with a collaboration among the American Statistical Association (ASA), PHUSE and the FDA.



Project Leads

Email

Melvin Munsaka

(

, Abbvie

)Neetu Sangari

Jiang (

Pfizer

Jessica)

neetu.sangari@pfizer.comPaula Rowley (

Hu, FDA

jiang.hu@fda.hhs.gov

Neetu Sangari, Pragya Tech Leadersneetusang@gmail.com
Kerry Robson, PHUSE Project Assistant
)
paula@phuse.gobal


Status
colourBlue
titleCurrent Status
Q1 2024

  • Participation at the CSS
  • Presentation at the FDA



.  title Q1 2023
  • Finalise Stage 1 documentation 
  • Project Members Eli Lilly
    Objectives & DeliverablesTimelines
    An open-source R Shiny tool for generating the plots and associated outputs and an accompanying paper for the tool
    Q3 2022
    Status
    colourBlue
    Current Status
    Complete manuscript
    Q4 2024
    Organisation 

    Hanming Tu 

    Frontage Laboratories

    Ivan Zou

    Sanofi

    Jeremy Wildfire

    Gilead

    Kyle Wathen  

    Gilead

    Mary Nilsson  

    Eli Lilly

    Mike Stackhouse

    Atorus Research
    Minchen WangGilead
    Neetu SangariPfizer

    Ting Zhang

    Sanofi
    Vaishali Popat

    FDA

    Vipin Arora

    Eli Lilly 

    Zachary Skrivanek